Author: Ilia

Recognized as one of the most life-threatening infections known today, HIV or the human immunodeficiency virus can progress to AIDS (acquired immunodeficiency syndrome (AIDS) if the right medical therapy is not administered. Thankfully, there is a way to inhibit the viruses’ objectives, and this way refers to the significant antiretroviral therapy. The said therapy involves …

Biktarvy Vs. AtriplaRead More

One of the standard regimens for treatment-naïve patients, based on the recommendations of the Department of Health and Human Services (DHSS), is a combination of Truvada + INSTI (integrase strand transfer inhibitor). Official HIV treatment guidelines are usually updated from year to year to reflect new findings from research trials and real-world effectiveness. PEP recommendations …

Truvada and Isentress: Effectiveness as HIV PEP TreatmentRead More

Treatment for HIV-infected patients has improved dramatically over the last several years. Almost all patients taking any form of antiretroviral treatment (ART) can achieve reduction in viral load and longer life expectancy. However, the success of ART relies heavily on patient adherence. Substance abuse, including alcohol consumption, remains an important factor that influences a patient’s …

Genvoya and Alcohol ConsumptionRead More

Hair loss or hair thinning is a possible consequence of taking antiretroviral meds, although not a common occurrence, especially in modern regimens. It can also be a direct result of having HIV-1 infection. Truvada, a fixed dose combination of emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF), is the only treatment approved for both HIV positive …

Truvada and Hair LossRead More

Genvoya and Stribild are both manufactured by Gilead Sciences for treating HIV-1 in adults and children 12 years and older. These 2 antiretroviral pills are taken once a day and are composed of four HIV meds that work synergistically to reduce the amount of virus in the body. Both products are very similar in composition …

Stribild vs Genvoya – Costs, Side Effects & Why Switching To GenvoyaRead More

Over the years, abnormal weight gain has been a common cause of concern among patients treated with antiretroviral therapy (ART) such as Triumeq. Amidst the revolutionary success of combination pills to combat HIV virus and improve the immune function of HIV patients, is the growing unease over the drugs’ unwanted side effect. Prior to the …

Triumeq and Weight GainRead More

The history of single-tablet regimens (STR) started with Atripla—the first and only approved STR for HIV-1 infection—until the introduction of Complera in 2011. Stribild was then released the following year. The makers of Atripla, Gilead Sciences, just recently gained approval to market Genvoya and mark another milestone in HIV treatment and prevention. Genvoya is included in the …

Genvoya vs CompleraRead More

Two of the major medications used in providing medical treatment to individuals with HIV are Complera and Atripla. These medications are used worldwide, in line with the rule and purpose of antiretroviral therapy. While both of these drugs share the same objective, they still have major differences. What are these differences, then? Read on to …

Complera Vs. AtriplaRead More